![Efthymios Deliargyris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 88 113 $ am 30.09.2026
Efthymios N.
Deliargyris is currently Chief Medical Officer at CytoSorbents Corp.
since 2020.
Formerly, served as Chief Medical Officer at PLx Pharma, Inc. from 2018 to 2020, Director-Cardiology & Interventional Cardiology at Athens Medical Center SA from 2004 to 2010, and Assistant Professor at Wake Forest University from 2001 to 2004.
Education includes a doctorate from National & Kapodistrian University of Athens.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYTOSORBENTS CORPORATION 0,72 % | 01.06.2026 | 22.593 ( 0,72 % ) | 88 113 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOSORBENTS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2020 |
| ATHENS MEDICAL C.S.A. | Corporate Officer/Principal | 01.01.2010 |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2004 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Athens Medical Center SA
 Athens Medical Center SA Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
